MedicaSafe, Inc.
Matt Ervin is a seasoned entrepreneur and executive with a robust background in technology and finance. As the Founder and Director of MedicaSafe since January 2012, Matt has led innovations in medication safety and efficacy through programmable packaging and cloud technologies tailored for complex prescriptions. Prior to this, Matt co-founded Plum Voice in 2001, serving as CEO until its acquisition by Teleo Capital in October 2023, where the company specialized in conversational AI and communication platforms. Earlier in Matt’s career, Matt worked as an Investment Analyst and Mutual Fund Manager at Baron Capital Group from 1997 to 2001, managing notable funds and leading analyses in technology and media investments. Matt holds both a Master's Degree in Applied Sciences and a Bachelor's Degree in Physics from Harvard University.
This person is not in any teams
This person is not in any offices
MedicaSafe, Inc.
MedicaSafe creates innovative technologies for guiding patients through high-stakes outpatient medication therapies. These solutions also address needs for regular patient assessment, tracking, and medication access management, enabling creation of comprehensive treatment management systems that reduce labor and costs while improving outcomes. Technology / Differentiation A patent-protected approach, developed with funding from the NIH, facilitates patient behavioral modification and patient tracking. The system can be geared to correct underuse of medication or, alternatively, limit drug access to prevent overuse. Market / Customers Lack of adherence/compliance in a clinical setting is estimated to produce 125,000 deaths and $100 billion in health care costs annually. MedicaSafe is targeting areas of specific applicability such as: 1) Risk Management (REMS) 2) High-Value Chronic Treatments 3) Clinical Trials